What's new

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 3, Status: Authorised

May 19, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisati...

Next Article

Standard operating procedure for validation, publication, and maintenance of rea...

Related Posts

Medicine shortage communication (MSC): Fiasp PumpCart a...

May 12, 2025  0

EVVET – Data warehouse user manual

May 16, 2025  0

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0